tert-Butyl 6-hydroxy-2-azaspiro[3.4]octane-2-carboxylate, 95.0%, 1g

1-Benzyl 4-(tert-butyl) 2-(hydroxymethyl)piperazine-1,4-dicarboxylate, 95+%, 1g

4-Hydroxydiphenylamine, 98.0%, 25g

3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one, 95.0%, 250mg

1-(4-Chlorophenyl)-2-pyrrolidinone, 95+%, 1g

4,5-Dimethyl-4H-1,2,4-triazol-3-amine hydroiodide, 97%, 1g

2,5-Dibromo-3,4-dinitrothiophene>98.0%(HPLC)1g

3-(tert-Butoxycarbonylamino)-1-propanol>96.0%(GC)25mL

1-(TERT-BUTOXYCARBONYLAMINO)-4,4-DIFLUOROCYCLOHEXANECARBOXYLIC ACID, 95.0%, 1g

Colonna capillare per GC ROTI®Cap-1701 MS, 60 m, 0.32 mm, 0.50 µm, 1 Pezzo(i)

Sodium 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate, 98.0%, 5g

(S)-tert-Butyl 3-(pyridin-2-yloxy)pyrrolidine-1-carboxylate, 95.0%, 1g

4-Cyano-4'-methylbiphenyl, 95.0%, 25g